Results 161 to 170 of about 10,015 (184)

Interim Restaging FDG-PET/CT to Guide Use of High Dose Sequential Induction Therapy with Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (RDICEP) and Rituximab-Carmustine, Etoposide, Cytarabine, Melphalan (RBEAM) and Autologous Stem Cell Transplantation (ASCT) for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials. Gov Identifier: NCT00530179.

Blood, 2009
Abstract Abstract 3414 Poster Board III-302 Purpose Approximately 50-55% of patients (pts) with stage 3-4 DLBCL and elevated serum LDH achieve long-term event-free survival (EFS) following R-CHOP chemotherapy.
Douglas A. Stewart, Peter Duggan, Nizar J Bahlis, Andrew Daly, Michelle Geddes, Reinhard Kloiber, Christian Fibich, David Blair Macdonald, Isabelle Bence-Bruckler   +8 more
openaire   +1 more source

Result disclosure on ClinicalTrials. gov — first experiences and challenges

Pharmaceutical Programming, 2010
AbstractThe disclosure of clinical trial 'basic' results on the website ClinicalTrials. gov has been legally required since September 2008 for all FDA-approved trials or cleared drugs and devices. Since that time, many additions (e.g.adverse event reporting in September 2009) and corrections (both content and format related) have been implemented.
openaire   +1 more source

T1192 A Randomized Trial of Metabolite-Adjusted Versus Weight-Based Dosing of Azathioprine (AZA) in Crohn's Disease (CD) [Clinicaltrials. Gov Identifier Nct00113503]

Gastroenterology, 2009
Themistocles Dassopoulos, Christopher F. Martin, Joseph Galanko, Douglas C. Wolf, Marla Dubinsky, Robert S. Sandler, Stephen B. Hanauer   +6 more
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

CHARACTERISTICS AND TRENDS OF CARDIOVASCULAR TRIALS: ANALYSIS OF CLINICALTRIALS. GOV LISTINGS FROM 2008 TO 2022

Journal of the American College of Cardiology
Gerald Chi, Laith Allaham, Alberto Castro Molina, Maria Cecilia Bahit, Serge Korjian, Clara Vitarello, Paul Nara, Alka Shaunik, C. Michael Gibson   +8 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi, Katherine A Hutcheson, Gary H Lyman   +2 more
exaly